Aspen Pharmacare Holdings Ltd., Africa’s largest drug manufacturer, recorded its biggest stock rally in 25 years after announcing plans to divest its Asia-Pacific operations (excluding China) to Australian private equity firm BGH Capital Pty Ltd. for R26.5 billion ($1.6 billion). The transaction covers Aspen’s businesses in Australia, Hong Kong, Malaysia, Taiwan, and the Philippines, representing … Continue reading Aspen Pharmacare to divest Asia-Pacific assets in $1.6 billion deal